Cube Biotech
PrivateLast Round
M&A
Nov 3, 2021
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cube Biotech operates in Healthcare & Life Sciences and is based in Monheim. Its latest recorded funding round was a Series A round in December 2012.
Cube Biotech is a biotechnology company that provides products and contract research organization (CRO) services for protein expression, purification, characterization, and stabilization to the pharmaceutical and biotech industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cube Biotech Comparables
Compare Cube Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bio-Works Technologies | 80% | |
| Agarose Bead Technologies | 79% | |
| Salipro Biotech AB | 78% |
For institutional investors. Book with your work email.
Cube Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Nov 3, 2021 | ||||
| Series A | Dec 1, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cube Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Creathor Venture | Series A |
| ARCHIMED | M&A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Open roles increased to 26, 2.4x the trailing average.
- Jun 20, 2026
Monthly visitors increased 30% MoM to 37.1K.
For institutional investors. Book with your work email.
Cube Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cube Biotech's valuation, stock price, and market status.
Is Cube Biotech a public or private company?
Cube Biotech is a private company.
What is the current stock price of Cube Biotech?
Cube Biotech is a private company, so its shares have no public market price. Caplight tracks Cube Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cube Biotech worth (valuation)?
Valuation information for Cube Biotech is not publicly available.
Can I buy Cube Biotech stock?
Cube Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cube Biotech's last funding round?
Cube Biotech's most recent funding round was M&A on November 3, 2021.
Who are the main investors in Cube Biotech?
Key investors in Cube Biotech include Creathor Venture, ARCHIMED.
Will Cube Biotech IPO soon?
No public IPO plans have been announced for Cube Biotech.
How can I track Cube Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Cube Biotech's shares on secondary markets.